# OR14A2

## Overview
OR14A2 is a gene that encodes the protein olfactory receptor family 14 subfamily A member 2, which is a member of the G-protein-coupled receptor (GPCR) family. This protein is primarily involved in the detection of odor molecules within the olfactory epithelium, where it plays a critical role in the signal transduction pathways that lead to the perception of smell. Beyond its traditional olfactory functions, OR14A2 is ectopically expressed in various non-olfactory tissues, such as the heart, skin, lungs, and intestinal epithelium, where it participates in diverse physiological processes, including immune response and inflammation regulation. The gene has also been implicated in pain perception, particularly in the context of cancer treatment, highlighting its potential involvement in pain pathways (Xu2021Enterochromaffin; Lee2019Genomewide). These findings suggest that OR14A2 has a broader role in human physiology beyond its established function in olfaction.

## Function
OR14A2 is an olfactory receptor gene that encodes a protein involved in the detection of odor molecules. This protein is part of the G-protein-coupled receptor (GPCR) family, which plays a crucial role in signal transduction processes. In healthy human cells, OR14A2 is primarily active in the olfactory epithelium, where it binds specific odorants. This binding initiates a signal transduction pathway that results in the perception of smell, contributing to sensory perception (Xu2021Enterochromaffin).

Beyond its role in olfaction, OR14A2 and other olfactory receptors are ectopically expressed in various non-olfactory tissues, including the heart, skin, lungs, and intestinal epithelium. In these tissues, they are involved in diverse physiological processes such as immune system activity, inflammation regulation, and potentially tumor growth and metastasis (Xu2021Enterochromaffin). OR14A2 has also been identified as a susceptibility gene for pretreatment pain in patients with head and neck tumors, suggesting a role in pain pathways (Lee2019Genomewide). The receptor's involvement in these processes highlights its significance beyond traditional olfactory functions, indicating a broader role in human physiology.

## Clinical Significance
The gene OR14A2, part of the olfactory receptor family, has been implicated in various physiological and pathological processes beyond its traditional role in odor detection. Alterations in the expression of OR14A2 have been associated with pain perception, particularly in the context of cancer treatment. Genome-wide analyses have identified OR14A2 as a susceptibility gene for pretreatment pain in patients with head and neck tumors, suggesting a potential link between its activity and pain pathways (Xu2021Enterochromaffin). In breast cancer patients, OR14A2 has been highlighted in studies exploring acute post-radiotherapy pain, where olfactory receptor genes, including OR14A2, may be involved in pain pathways via the MAPK signaling pathway (Lee2019Genomewide).

The expression of OR14A2 in non-olfactory tissues, such as the heart, skin, lungs, and intestinal epithelium, indicates its involvement in broader physiological functions, including inflammation regulation and tumor growth (Xu2021Enterochromaffin). Despite these associations, specific clinical conditions directly resulting from mutations in OR14A2 are not well-documented, and further research is needed to elucidate its precise role in disease mechanisms.


## References


[1. (Xu2021Enterochromaffin) Xiaolin Xu, Rongmin Chen, Gaofeng Zhan, Danning Wang, Xi Tan, and Hui Xu. Enterochromaffin cells: sentinels to gut microbiota in hyperalgesia? Frontiers in Cellular and Infection Microbiology, October 2021. URL: http://dx.doi.org/10.3389/fcimb.2021.760076, doi:10.3389/fcimb.2021.760076. This article has 22 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcimb.2021.760076)

[2. (Lee2019Genomewide) Eunkyung Lee, Cristiane Takita, Jean L. Wright, Susan H. Slifer, Eden R. Martin, James J. Urbanic, Carl D. Langefeld, Glenn J. Lesser, Edward G. Shaw, and Jennifer J. Hu. Genome-wide enriched pathway analysis of acute post-radiotherapy pain in breast cancer patients: a prospective cohort study. Human Genomics, June 2019. URL: http://dx.doi.org/10.1186/s40246-019-0212-8, doi:10.1186/s40246-019-0212-8. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s40246-019-0212-8)